isoconazole Injection 372 mg
Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
FDA, China
Manufacturer #8101
A pharmaceutical manufacturer offering both active pharmaceutical ingredients (APIs) and finished dosage pharmaceutical products, with multiple production bases and full-chain capabilities from raw materials to formulations. The company has passed cGMP certifications in China, Europe and the U.S., with manufacturing lines for injectables, oral solids and other complex dosage forms, and supports global exports with extensive R&D and CDMO/CMO services.
Manufacturer usually replies in 40 days
None